Submitted by dad2032 on November 22, 2016 - 12:51pm
| Title | A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC) |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Beltran H, Danila D, B M, Szmulewitz R., Vaishampayan U, Armstrong A., Stein M., Hoimes C, Pinski J., Scher H., Puca L, Bareja R., Wong W., Rubin M., Mosquera J.M., Sboner A, Oromendia C., Nanus D, Ballman K., Tagaqa S.T |